ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
3.770
+0.010 (0.27%)
At close: Apr 28, 2026, 4:00 PM EDT
3.900
+0.130 (3.45%)
After-hours: Apr 28, 2026, 7:16 PM EDT
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $479.50 million as of April 28, 2026. Its market cap has increased by 332.09% in one year.
Market Cap
479.50M
Enterprise Value
657.72M
1-Year Change
332.09%
Ranking
Category
Stock Price
$3.77
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $479.50M, a decrease of -76.53%. That is a compound annual growth rate of -21.61%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lyell Immunopharma | 522.79M |
| Eikon Therapeutics | 522.71M |
| Immix Biopharma | 522.17M |
| Fulcrum Therapeutics | 522.15M |
| Verastem | 519.15M |
| Zura Bio | 510.46M |
| MiMedx Group | 509.58M |
| Upstream Bio | 506.11M |